Page 33 - Special Access Program News Today

27.05.2022 - Halucenex to receive recently harvested first batch of psilocybe cubensisVANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian ... Seite 1

KULR Technology Group Inc, a leading developer of next-generation lithium-ion battery safety and thermal management technologies, told investors that it had...

The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter...

KULR Technology Group Inc, a leading developer of next-generation lithium-ion battery safety and thermal management technologies, told investors that it had...

/PRNewswire/ - Numinus Wellness Inc. ("Numinus") (TSX: NUMI) (OTC: NUMIF), a mental health care company advancing innovative treatments and safe,...

Numinus Wellness Inc. (TSX-V:NUMI, OTC:LKYSF) announced that it has been granted approval from Health Canada to carry out psychedelic-assisted therapy using...

Through the Partnership, the Company will seek Health Canada approval to supply naturally-derived psilocybin for legal and therapeutic use via the Special Access Program   May 16, 2022,

/CNW/ - Albert Labs International Corp. (CSE: ABRT) (FSE: VB50) (the "Company"), a research and drug development company using advanced culture technology to...

KULR Technology Group Inc, a leading developer of next-generation lithium-ion battery safety and thermal management technologies, told investors that it had...

Albert Labs International Corp (CSE:ABRT) said it has been granted a Health Canada license for its research and production facility in Burnaby, Canada,...